Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Christopher Singh (NPI 1083724900)

Field	Value
Entity Type	Individual
Organization	Christopher Singh
Address	8562 Holly Rd
City	Grand Blanc
State	MI
ZIP	48439
Taxonomy	Ophthalmology Physician
NPI Enumerated	August 30, 2006

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the available data: total Medicare revenue is $1.7M and there is no Medicaid billing on file. The absence of any Medicaid claims indicates the practice’s revenue stream in the dataset is concentrated entirely in Medicare rather than split across public payers.

Revenue is highly concentrated in a small set of intravitreal/injection and retina procedure codes: the precomputed top three Medicare codes (J2777, J0178, 67028) account for 82.3% of this provider’s total Medicare revenue. Specifically, J2777 produced $760.4K (46.0%), J0178 produced $501.6K (30.4%), and 67028 produced $97.3K (5.9%) of Medicare revenue, confirming a narrow revenue base focused on a few high‑value services.

Clinical mix and service line implications point to a retina‑focused ophthalmology practice centered on intravitreal therapy and related procedures. The dominant codes are drug injection codes (J2777 faricimab, J0178 aflibercept, and J2778 ranibizumab) plus an isolated intravitreal injection procedure (67028), which together indicate the provider primarily delivers office‑based retinal injections for macular disease and related conditions.

Competitive standing on the highest‑revenue drugs is modest rather than dominant: J2777 is $760.4K and ranks #361 of 2039 providers (82th percentile; typical, unremarkable volume for this code), while J0178 is $501.6K and ranks #1592 of 3204 providers (50th percentile; typical, unremarkable volume). The 67028 procedure ($97.3K) ranks #1239 of 4255 providers (71th percentile; typical, unremarkable volume), so the provider participates at typical national volumes for its leading revenue drivers rather than being an outlier or market leader.

There is a notable imaging intensity relative to the provider’s scale: 92134 (retinal OCT imaging) shows 1.6K claims, $42.2K revenue (2.6%) and ranks #1457 of 26868 providers (95th percentile; notably above typical national volume). This elevated percentile for 92134 suggests the practice pairs frequent diagnostic retinal imaging with its injection services, supporting a treatment workflow that relies on OCT monitoring.

Evaluation and management (E/M) activity is present but not the primary revenue driver: 99214 generated $40.7K (2.5%) from 452 claims and ranks #57544 of 479517 providers (88th percentile; typical, unremarkable volume), while 99213 contributed $13.3K (0.8%). These figures show routine office visits accompany the procedure‑heavy mix but that injections and related retinal procedures dominate billing and revenue.

The provider’s therapeutic mix includes both high‑cost branded agents and lower‑cost alternatives or implants, indicating clinical flexibility in treatment selection. J9035 bevacizumab appears with 358 claims and $19.7K revenue (1.2%) ranked #394 of 1852 providers (79th percentile; typical, unremarkable volume), and J7312 (dexamethasone intravitreal implant) contributed $49.8K (3.0%) and ranks #148 of 492 providers (68th percentile; typical, unremarkable volume), showing use of multiple pharmacologic options beyond the top branded agents.

The provider has a long tenure in Medicare billing, with an NPI enumeration date of 2006-08-30 (~20 years ago), indicating an established presence in the Grand Blanc, MI market. Given this longevity combined with the practice’s heavy dependence on Medicare ($1.7M) and no Medicaid billing, analysts should view the provider as a stable, Medicare‑focused retinal injector practice with concentrated revenue around a few high‑volume injection codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	26,220	$30	$760.4K
J0178	Injection, aflibercept, 1 mg	730	$690	$501.6K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,120	$90	$97.3K
J2778	Injection, ranibizumab, 0.1 mg	410	$180	$75.3K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	320	$160	$49.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,560	$30	$42.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	450	$90	$40.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	250	$90	$21.3K
J9035	Injection, bevacizumab, 10 mg	360	$60	$19.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	230	$60	$13.3K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Christopher Singh — 2 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	54	110	680	$690	$630.2K
J2777	5	60	7,200	$30	$321K
J2778	33	50	730	$180	$240.5K
67028	30	160	440	$90	$57.6K
J7312	1	10	230	$150	$36.1K
92014	264	1,080	100	$80	$14.8K
99214	958	15,470	80	$80	$11.4K
J9035	4	30	70	$50	$9.5K
92134	33	820	60	$30	$7.1K
67228	28	30	30	$250	$6.7K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Christopher Singh, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ankur Mehta	MI	Ophthalmology Physician	$1.6M	$0
Paul Raphaelian	MI	Retina Specialist (Ophthalmology) Physician	$1.5M	$0
Raafay Sophie	MI	Ophthalmology Physician	$839.4K	$0
Sundhar Ramasamy	MI	Ophthalmology Physician	$797.6K	$0
Melanie Mihlstin	MI	Ophthalmology Physician	$585.2K	$0
Vikas Chopra	CA	Ophthalmology Physician	$430.6K	$0
Gregory Hazen	MI	Ophthalmology Physician	$233.5K	$0
Tim Pan	MI	Ophthalmology Physician	$168.2K	$0
Rajesh Rao	MI	Ophthalmology Physician	$21.7K	$0

Nearby Providers

Other providers in the same ZIP code as Christopher Singh, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Henry Ford Health Genesys Hospital	MI	General Acute Care Hospital	$0	$31.4M
Helping Hand Nursing Service, Inc	MI	Home Health Agency	$0	$9.2M
Grand Blanc Pediatric Dentistry PC	MI	Pediatric Dentistry	$0	$6.2M
Emergency Medicine Physicians Of Genesee County, PLLC	MI	Emergency Medicine Physician	$0	$5.8M
Riad Dali Ahmad	MI	Infectious Disease Physician	$1.1M	$0
The Center For Gastrointestinal Health At Health Park LLC	MI	Ambulatory Surgical Clinic/Center	$475.5K	$545.6K
Surgery Center At Health Park LLC	MI	Ambulatory Surgical Clinic/Center	$699.9K	$15.3K
Thomas Shuster	MI	Vascular Surgery Physician	$532.5K	$0
Arvind Kunadi	MI	Nephrology Physician	$339.3K	$0
Rajakumari Swamy	MI	Internal Medicine Physician	$296.4K	$0

Christopher Singh — Billing Profile & Reimbursement Data

Sign up for Christopher Singh — Billing Profile & Reimbursement Data policy alerts

Christopher Singh — Billing Profile & Reimbursement Data

Sign up for Christopher Singh — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References